http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6156299-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66cfb9f10ffa12406849eb8366ab4f10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-342
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-361
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-368
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-345
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-37
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-368
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60
filingDate 1999-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2000-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89b14095ecf71c889213e3c75eccc5c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ed4709e2a07fb0d75458d1ae87dcc26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b08fbbf868f8d331773844f39d52fcc
publicationDate 2000-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6156299-A
titleOfInvention Topical compositions and methods for treating pseudofolliculitis barbae and ingrown hair
abstract Topical compositions and methods are disclosed for the treatment of pseudofolliculitis barbae and ingrown hair. The compositions comprise acetylsalicylic acid, propylene glycol, glycerine, and isopropyl alcohol. The method involves the step of applying the composition to the beard areas of the face after shaving. The acetylsalicylic acid is dissolved in a solvent mixture comprising propylene glycol, glycerine, and isopropyl alcohol. The acetylsalicylic acid is present in the range of between about 5 percent by weight per unit volume of the solvent mixture up to saturation of the solvent mixture. The solvent mixture comprises propylene glycol in the range of about 5 to 15 percent by volume, glycerine in the range of about 1 to 10 percent by volume, and the balance of the volume made up with isopropyl alcohol alone or a solution comprising at least 50 percent by volume of isopropyl alcohol. The isopropyl alcohol can be in a solution with water, methanol, or ethanol, provided that the polarity of the resulting solution is not so high that the acetylsalicylic acid would readily precipitate from the solution at ordinary room temperature ranges.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003077308-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10561591-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7404949-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011201578-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10406094-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7985743-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10117819-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6503488-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6703009-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10660835-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2191815-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10258555-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10111815-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004018158-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10111820-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7238680-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10632054-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10980723-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005202054-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004241131-A1
priorityDate 1993-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4185100-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5204093-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3136696-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4946870-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5223267-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4199576-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4665063-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5747021-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5034221-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127759454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID259994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54404402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129509037
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405496

Total number of triples: 61.